Publications

Search ACTG publications from 1/1/2006 to current.

Search

Filter results by

Found 7 results
Filters: First Letter Of Last Name is N  [Clear All Filters]
Found 7 results.
Skip Alphabet Links A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z  

N

Naggie S, Patel K, Yang L-Y, et al. "Antiretroviral Effects on Host Lipoproteins Are Associated With Changes in Hepatitis C Virus (HCV) RNA Levels in Human Immunodeficiency Virus/HCV Coinfected Individuals." Open Forum Infect Dis. 2015;2(2):ofv066.
Naggie S, Marks KM, Hughes M, et al. "Sofosbuvir Plus Ribavirin Without Interferon for Treatment of Acute Hepatitis C Virus Infection in HIV-1-Infected Individuals: SWIFT-C." Clin. Infect. Dis.. 2017;64(8):1035-1042.
Natsag J, Kendall MA, Sellmeyer DE, McComsey GA, Brown TT. "Vitamin D, osteoprotegerin/receptor activator of nuclear factor-kappaB ligand (OPG/RANKL) and inflammation with alendronate treatment in HIV-infected patients with reduced bone mineral density." HIV Med.. 2016;17(3):196-205.
Neto MF, Butzler MA, Reed JL, et al. "Immiscible phase filter extraction and equivalent amplification of genotypes 1-6 of hepatitis C RNA: The building blocks for point-of-care diagnosis." J. Virol. Methods. 2017;248:107-115.
Nielsen-Saines K, Komarow L, Cu-Uvin S, et al. "Infant outcomes after maternal antiretroviral exposure in resource-limited settings." Pediatrics. 2012;129(6):e1525-32.
Nixon DE, Bosch RJ, Chan ES, et al. "Effects of atorvastatin on biomarkers of immune activation, inflammation, and lipids in virologically suppressed, human immunodeficiency virus-1-infected individuals with low-density lipoprotein cholesterol <130 mg/dL (AIDS Clinical Trials Group Study A5." J Clin Lipidol. 2017;11(1):61-69.
Noviello CM, Pond SLKosakovs, Lewis MJ, et al. "Maintenance of Nef-mediated modulation of major histocompatibility complex class I and CD4 after sexual transmission of human immunodeficiency virus type 1." J. Virol.. 2007;81(9):4776-86.